Excalipoint Therapeutics News and Activities

Acquisition, funding and merger involving Excalipoint Therapeutics.

• Excalipoint Therapeutics has just announced a $68 Million fundraising (posted on May 7 2026).

View the org chart displaying its 9 main executives

Most searched biographies at Excalipoint Therapeutics

• Lei Fang, Chief Executive Officer
• Cong Shen, Vice President, Chemistry, Manufacturing and Controls
• Jielun Zhu, Chief Financial and Business Officer

Create your alert
to follow the executive moves at Excalipoint Therapeutics.

Excalipoint Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Excalipoint Therapeutics

Social media about Excalipoint Therapeutics

• Excalipoint Therapeutics on Wikipedia, Google News & Yahoo Finance
• Excalipoint Therapeutics on LinkedIn, X (Twitter) & YouTube